Saturday, July 11, 2026

pharma · Sepsis · Tumor, Solid

Sichuan Kelun Pharmaceutical

Sichuan Kelun Pharmaceutical trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
375 Employees
NMPA registrant Type
Company details
Status
Public
HQ
CN
Employees
375
Programs
4
Drugs
6
Patents
0
Intelligence · Clinical Trials

Sichuan Kelun Pharmaceutical clinical trials

Registry index of 4 ClinicalTrials.gov studies linked to Sichuan Kelun Pharmaceutical programs — each row shows trial ID, program name, phase, status, and indication.

Sichuan Kelun Pharmaceutical trial registry — 4 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

4 updates

Latest clinical program signals indexed for Sichuan Kelun Pharmaceutical.

  1. SKB103 for injection monotherapy — Phase 2

    Clinical update
  2. Radiation: 18F-AlF-FAPi-04 — Phase 1

    Clinical update
  3. rSIFN-co — Phase 1

    Clinical update
  4. Mecobalamin — Approved

    Clinical update

Trial registry

4 studies